Alex Lugovskoy, PhD, an author of over 100 patents and an expert in antibody R&D, is working hard to unlock one of the most important areas of drug discovery and development: agonist antibodies for ...
Sometimes you come across one of those ideas that at first appear to have to be some kind of elaborate joke, but as you dig deeper into it, it begins to make a disturbing kind of sense. This is where ...
Diagonal Therapeutics is taking shape, launching with $128 million and backed by the likes of BVF Partners, Atlas Venture and RA Capital to develop a pipeline of antibody agonists. The company will ...
WATERTOWN, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering antibodies that address the underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback